Nexentis Technologies Inc. SEC filings NXTS
Nexentis Technologies Inc. has 309 filings in SEC EDGAR's recent list, going back to Sep 26, 2019. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (unregistered share sale, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 17, 2026 | — |
| EFFECT | Filing | Jul 15, 2026 | — |
| EFFECT | Filing | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 28, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2025 | — |
| CORRESP | Letter to the SEC | Mar 12, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 6, 2025 | — |
| EFFECT | Filing | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Feb 14, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 24, 2025 | — |
| EFFECT | Filing | Feb 6, 2024 | — |
| CORRESP | Letter to the SEC | Feb 5, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2024 | — |
| EFFECT | Filing | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2023 | — |
| DEL AM | Filing | Oct 12, 2023 | — |
| DEFR14A | Filing | Aug 24, 2022 | — |
| EFFECT | Filing | Jul 22, 2022 | — |
| CORRESP | Letter to the SEC | Jul 20, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2022 | — |
| NT 10-Q | Filing | May 17, 2021 | Mar 31, 2021 |
| EFFECT | Filing | May 13, 2021 | — |
| CERT | 8a cert | May 13, 2021 | — |
| 8-A12B | Filing | May 11, 2021 | — |
| CORRESP | Letter to the SEC | May 11, 2021 | — |
| CORRESP | Letter to the SEC | May 11, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2021 | — |
| DRS | Filing | Dec 28, 2020 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2020 | — |
| 10-12G/A | Filing | Dec 31, 2019 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2019 | — |
| 10-12G/A | Filing | Dec 11, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2019 | — |
| CORRESP | Letter to the SEC | Nov 14, 2019 | — |
| 10-12G/A | Filing | Nov 14, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2019 | — |
| 10-12G | Filing | Sep 26, 2019 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NXTS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1789192
- Former names
- N2OFF, Inc. (until Feb 25, 2026); Save Foods, Inc. (until Mar 19, 2024); Save Foods Inc. (until Apr 10, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.